Aayush Wellness Limited has launched Lung Care Tablets as part of its efforts to expand its preventive healthcare and nutraceutical portfolio. The new product is aimed at supporting respiratory wellness amid growing concerns around smoking, air pollution and environmental exposure.
The launch follows the company’s earlier introduction of Aayush Herbal Masala, which was developed around health concerns linked to smokeless tobacco consumption. With Lung Care Tablets, the company is extending its focus to respiratory health and building a broader portfolio based on changing consumer health needs.
India’s respiratory healthcare market has shown steady growth in recent years. According to data cited by the company, the Respiratory System therapeutic segment recorded sales of ₹18,912.64 crore in 2025, compared with ₹17,199.40 crore in 2024, representing growth of around 10%.
Aayush Wellness said the growing burden of respiratory diseases and increasing awareness of lung health have created a need for preventive wellness products. Urban consumers are increasingly exposed to air pollution, smoking, occupational pollutants and other environmental factors that can affect respiratory health.
The company cited Global Burden of Disease data, according to which India accounts for 15.69% of global chronic respiratory disease cases and 30.28% of global deaths linked to respiratory diseases. Aayush Lung Care Tablets contain a combination of N-Acetyl Cysteine (NAC), Vasaka Extract, Licorice, Quercetin, Vitamin C, Vitamin D2 and Zinc. The formulation combines herbal ingredients with nutritional and functional ingredients commonly used in respiratory and immune-support products.The tablets are designed to support respiratory wellness, healthy airway function, antioxidant and immune support, a healthy inflammatory response and overall lung health maintenance.
Naveenakumar Kunjaru, Managing Director of Aayush Wellness Limited, said the company’s focus has always been on identifying changing health concerns and developing accessible wellness solutions. He said the launch of Lung Care Tablets extends the prevention-focused approach of the company into respiratory wellness, where air pollution, smoking and environmental exposure have become growing concerns.
The addition of the new product is also expected to strengthen Aayush Wellness’ nutraceutical portfolio and expand its presence across the preventive healthcare market. The company sees opportunities to offer a wider range of products to its existing customer base while addressing new consumer requirements.
Aayush Wellness Limited [BSE Scrip Code: 539528, MSEI Symbol: AAYUSH], established in 1984, is an Indian health and wellness company focused on preventive healthcare and consumer wellbeing.
The company is committed to offering quality products and services designed to support healthier lifestyles and improve overall wellbeing. Aayush Wellness combines innovation with wellness to develop solutions that address the changing needs of consumers.
With a diverse range of wellness products and services, the company continues to promote preventive healthcare and encourage people to make healthier lifestyle choices. Aayush Wellness aims to make wellness solutions more accessible while focusing on quality, innovation and consumer needs.
Over the years, the company has built its presence in the health and wellness sector by focusing on products and services that support everyday wellbeing. Its approach is centred on preventive healthcare, with the aim of helping consumers take a more proactive approach towards maintaining their health and wellness.
Aayush Wellness Limited continues to expand its offerings and strengthen its position in India’s growing health and wellness market. The company remains focused on developing innovative wellness solutions that contribute to a healthier and more informed society.
